Recent Articles from Business Wire

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Banco Santander, S.A. (“Santander” or “the Company”) (NYSE: SAN) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Babcock & Wilcox Enterprises, Inc. (“B&W” or “the Company”) (NYSE: BW) for violations of the securities laws.

Kardigan™, a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced results from KARDINAL, a Phase 2 clinical trial evaluating the effects of tonlamarsen in patients with uncontrolled hypertension despite treatment with two or more antihypertensive medications. Data were presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.26) and simultaneously published in The Journal of the American College of Cardiology (JACC). In the clinical trial, tonlamarsen, an investigational antisense oligonucleotide (ASO) targeting angiotensinogen (AGT), demonstrated a statistically significant reduction in plasma AGT levels and a clinically meaningful reduction in in-office systolic blood pressure (oSBP) from baseline to Week 20. These results highlight the intended biological effect of tonlamarsen and support evaluation in Kardigan’s planned Phase 2b clinical trial in patients with acute severe hypertension (ASH) post-hospitalization.

Debevoise & Plimpton LLP has secured affirmance from the U.S. Court of Appeals for the Second Circuit of its 2023 summary judgment win on behalf of YPF S.A., the largest energy producer in the Republic of Argentina – defeating claims for more than $16 billion in damages and interest. This is a landmark win for YPF, affirming the dismissal of a case that has been pending in S.D.N.Y since 2015. The Second Circuit fully affirmed the District Court’s holding that YPF did not owe the alleged contractual obligations to Petersen Energía Inversora, S.A.U. and Petersen Energía, S.A.U. or Eton Park Capital Management, L.P., Eton Park Master Fund, Ltd., and Eton Park Fund, L.P., and is not liable for the damages Plaintiffs – and their litigation funder, Burford Capital – had claimed.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Yiren Digital Ltd. (“Yiren” or “the Company”) (NYSE: YRD) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or “the Company”) (NASDAQ: PODD) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Priority Technology Holdings, Inc. (“Priority Technology” or “the Company”) (NASDAQ: PRTH) for potential breaches of fiduciary duty on the part of its directors and management.

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT).

Takeda (TSE:4502/NYSE:TAK) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented late-breaking data from its MOMENTUM trial examining the prevalence of endogenous hypercortisolism in patients with resistant hypertension at the 2026 American College of Cardiology Annual Scientific Session (ACC 2026).

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting.

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD) that detects early signs of PH, a serious and progressive condition affecting the lungs and right side of the heart. The algorithm, which previously received FDA Breakthrough Device Designation, is the first PH algorithm cleared for use with standard 12-lead electrocardiograms (ECGs), making it broadly accessible across care settings.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced long-term efficacy and safety data from a two-year long open-label extension (OLE) study of investigational plozasiran supporting its potential as therapeutic solution for a diverse spectrum of patients with hypertriglyceridemia (HTG).

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ImmunityBio, Inc. (NASDAQ: IBRX) publicly traded securities between January 19, 2026 and March 24, 2025, both dates inclusive (the “Class Period”), have until May 26, 2026 to seek appointment as lead plaintiff of the ImmunityBio class action lawsuit. Captioned Douglas v. ImmunityBio, Inc., No. 26-cv-03261 (C.D. Cal.), the ImmunityBio class action lawsuit charges ImmunityBio and ImmunityBio’s Executive Chairman with violations of the Securities Exchange Act of 1934.

Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when switching adult outpatients with schizophrenia from an oral atypical antipsychotic to Cobenfy monotherapy. Through 8 weeks, patients remained stable with mean Positive and Negative Syndrome Scale (PANSS) total scores remaining below baseline, and no new safety signals were observed, regardless of cross-titration duration. These findings provide important evidence to help inform treatment switch strategies in clinical practice. Data were presented at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS) taking place March 25-29 in Florence, Italy.

Visa, the Official Payment Technology Partner of the FIFA World Cup 26™, together with national nonprofit Street Soccer USA and Bank of America, the Official Bank Sponsor of the FIFA World Cup 26™, today announced a significant expansion of Visa Street Soccer Parks, bringing a new park to every host city in the U.S. ahead of this summer’s tournament.

Nicklaus Companies LLC (the “Company”), home to some of the most prestigious global brands in golf, and a worldwide leader in golf-course design, today announced that it has successfully closed on the sale of substantially all of its assets, including its licensing and design businesses, to 20 Majors, LLC (the “Buyer” or “20 Majors”), an investment group led by Jack Nicklaus.

The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

Lantern Pharma Inc. (NASDAQ: LTRN) (“Lantern” or the “Company”), an AI‑driven, clinical‑stage oncology company leveraging its proprietary RADR® platform to transform the cost and timeline of cancer drug development, today issued the following statement in response to an article published earlier today on an unverified third‑party website.

Kolibri Global Energy Inc. (the Company or Kolibri) (TSX: KEI, NASDAQ: KGEI) today announces that, following thoughtful consideration, the board of directors of Kolibri, or the Board, have resolved to nominate the individuals proposed by Tetragon Partners UK LLP for election to the Board by the shareholders of the Company at the Company’s upcoming annual general meeting of shareholders, or the Meeting, which is expected to be held on May 4, 2026. The management nominees in respect of the Meeting will be existing directors David Neuhauser and Wolf Regener (CEO), as well as Glen Brown, Lee Canaan and Murray Grigg.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Vital Farms, Inc. (NASDAQ: VITL) between May 8, 2025 and February 26, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Vital Farms investors under the federal securities laws.

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Vital Farms, Inc. (NASDAQ: VITL) securities between May 8, 2025 and February 26, 2026. Vital Farms purports to be an ethically minded food company that became the leading U.S. brand of pasture-raised eggs and second largest U.S. egg brand by retail dollar sales.

Los Angeles is charting a bold new course into the Deep Blue Decade. Los Angeles Harbor College, in partnership with the California Community Colleges Chancellor’s Office, AltaSea at the Port of Los Angeles, and a consortium of 14 colleges, announced the next wave of Blue Economy workforce development through the 3rd Annual Blue Economy & Climate Action Pathways (BECAP) Summit — a landmark collaboration shaping the workforce ecosystems of tomorrow.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities during the period of January 19, 2026 through March 24, 2026, inclusive (“the Class Period”).

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today provided a corporate update following the filing of its 10-K on Friday, March 27, 2026, which reported financial results for the fourth quarter and year ended December 31, 2025.

Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to a Government Accountability Office (GAO) report examining the Center for Medicare and Medicaid Innovation (CMMI):

The Foundation for the Development of Western Syria (the “Foundation”) expresses its strongest condemnation of a series of extremist attacks and coordinated movements witnessed across several Syrian provinces. These developments represent a dangerous escalation that threatens Syria’s social fabric and specifically targets the country’s indigenous Christian community.

UWMC today issued the following statement regarding its proposal to acquire TWO.

The Law Offices of Frank R. Cruz announces an investigation of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) and reminds investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

On March 27, 2026, the Fairholme Focused Income Fund (“FOCIX” or the “Fund”) distributed an Ordinary Income dividend of $0.07347 per share to shareholders of record as of March 26, 2026. The Fund’s Net Asset Value (“NAV”) was reduced by the amount of the distribution.

Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to shareholders of record as of the close of business on April 10, 2026.

ZIVO Bioscience, Inc. (OTCQB: ZIVO), today issued the following letter to shareholders from Chairman, President and Chief Executive Officer John B. Payne.

Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), a technology company with a mission to enable the world’s transition to sustainable materials, today announced financial results for its fourth quarter and full year ended December 31, 2025.

The Board of Directors of Liberty All-Star Growth Fund, Inc. (the “Fund”) (NYSE: ASG) has appointed Congress Asset Management Company, LLP (“Congress”) as the investment manager for the small-cap growth portion of the Fund’s portfolio effective April 1, 2026 replacing Weatherbie Capital, LLC.

Virtus Total Return Fund Inc. (NYSE: ZTR) previously announced the following monthly distribution on March 4, 2026:

CBL Properties (NYSE:CBL) today announced that it has closed on a $176 million floating‑rate, non‑recourse loan secured primarily by a pool of three lifestyle and open‑air centers. The financing represents the second and final component of the Company’s refinancing of its former $634 million secured term loan.

Reference is made to the announcement made by Hafnia Limited ("Hafnia", the "Company", OSE ticker code: "HAFNI", NYSE ticker code: "HAFN") on 27 January 2025 regarding the finalisation of the share buyback program announced on 2 December 2024.

Verde Clean Fuels, Inc. (“Verde” or the "Company”) (NASDAQ: VGAS) announced today financial results for the fourth quarter and full year 2025.

indie Semiconductor (Nasdaq: INDI), an automotive solutions innovator, today announced that it has granted equity awards (the “Inducement Grants”) under its 2023 Inducement Incentive Plan to new employees who joined indie. The grants were previously approved by the Compensation Committee of the Board of Directors of indie Semiconductor. Information regarding the equity awards can be found on the company's investor relations website at: https://investors.indie.inc/news/default.aspx

Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO) previously announced the following monthly distribution on March 4, 2026:

The 19(a) distribution notices for six Nuveen closed-end funds are now available. These informational notices provide further details on the sources of the funds’ regular quarterly distributions and follows the most recent quarterly distribution announcements. The full text of these notices is available below or on the Nuveen website via Distribution Source Estimates.

Core & Main, Inc. (NYSE: CNM), a leading specialty distributor dedicated to advancing reliable infrastructure with local service, nationwide, today announced changes to its board of directors and executive chair, effective April 1, 2026, as part of the Company’s long-term succession planning.

Virtus Diversified Income & Convertible Fund (NYSE: ACV) previously announced the following monthly distribution on March 4, 2026:

KBRA releases research examining the impact of artificial intelligence (AI) on software and private credit portfolios.

Fastenal Company (Nasdaq:FAST) ('Fastenal,' 'we,' 'our,' or 'us') announced the date and time for its conference call to review 2026 first quarter results, as well as current operations. The conference call will be broadcast live over the Internet on Monday, April 13, 2026, at 9:00 a.m. central time.

Immersion Corporation (“Immersion”, the “Company”, “we”, “us” or “our”) (Nasdaq: IMMR), a leading provider of technologies for haptics, today announced that, on March 24, 2026, the Company received an additional delinquency notice (the “Staff Determination Letter”) from the Nasdaq Listing Qualifications Staff based on the Company’s failure to file its Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2026 indicating that such failure to file, in addition to its failure to file the Quarterly Reports on Form 10-Q for the fiscal quarters ended July 31, 2025 and October 31, 2025 with the Securities and Exchange Commission (the “SEC”) on a timely basis, could serve as an additional basis for delisting from the Nasdaq.

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection (the “Company”), today announced that the Company’s 2026 annual meeting of shareholders (the “Annual Meeting”) will be held virtually, by means of remote communication, on Tuesday, June 9, 2026 at 10:00 am Eastern Time. Stockholders of record of the Company’s common stock as of the close of business on April 14, 2026 will be entitled to vote at the Annual Meeting. Additional information regarding the Annual Meeting will be provided in the Company’s proxy statement.

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said.

object studio, creator of the recently announced Bella loyalty platform - providing a cohesive loyalty app, kiosk, member portal, and digital signage solution - is excited to announce a strategic partnership and integration with Playersoft, a leader in casino loyalty and player development solutions. The collaboration will see Bella integrate with Playersoft ONE – the next evolution of Playersoft’s award-winning mobile technology: combining legacy enrollment, group, and event management.

AM Best has placed under review with developing implications the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” (Excellent) of Equitable Financial Life Insurance Company of America (EFLICOA) (Phoenix, AZ) and Equitable Financial Life Insurance Company (EFLIC) (New York, NY). EFLICOA and EFLIC collectively are referred to as Equitable Life Group. Concurrently, AM Best has placed under review with developing implications the Long-Term ICR of “bbb+” (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of Equitable Holdings, Inc. (Delaware).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lufax Holding Ltd. (“Lufax” or the “Company”) (NYSE: LU) securities between April 7, 2023 and January 26, 2025, inclusive (the “Class Period”). Lufax investors have until May 20, 2026 to file a lead plaintiff motion.

AM Best has placed under review with developing implications the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “a” (Excellent) of the subsidiaries of Corebridge Financial, Inc. (Corebridge Financial). (Please see below for a detailed list of the companies and ratings.)

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) investors who purchased Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about September 12, 2025 (the “IPO” or “Offering”) and/or securities between September 12, 2025 and February 17, 2026, inclusive (the “Class Period”). Gemini investors have until May 18, 2026 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026, inclusive (the “Class Period”). Atara investors have until May 22, 2026 to file a lead plaintiff motion.

IVF Academy USA, the rapidly growing training institution for embryologists and fertility laboratory professionals, today announced the launch of its new OBGYN Clinic-Ready Fertility Services Accelerator Program, a 30-hour hybrid training designed to help board-certified OBGYNs integrate fertility services directly into their practices.

KBRA assigns a long-term rating of AAA to the Metropolitan Atlanta Rapid Transit Authority Sales Tax Revenue Bonds, Refunding Series 2026A (Green Bonds). KBRA additionally affirms the long-term rating of AAA for outstanding Sales Tax Revenue Bonds. The rating Outlook is Stable.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026, inclusive (the “Class Period”). Coty investors have until May 22, 2026 to file a lead plaintiff motion.

Irenic Capital Management, LP, one of the largest shareholders of Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX) with 2% ownership, today issued the following statement regarding the Company’s recent announcement:

The DJS Law Group reminds investors of a class action lawsuit against Coty Inc. (“Coty” or “the Company”) (NYSE: COTY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Willis Lease Finance Corporation’s (NASDAQ:WLFC) board of directors as well as executive chairman Charles F. Willis, IV (as the controlling stockholder) for potential breaches of their fiduciary duties to shareholders in connection with Willis Lease’s past and ongoing practices of paying potentially excessive compensation to Mr. Willis.

Certified Financial Planner Board of Standards, Inc. (CFP Board), a nonprofit organization with more than 107,000 CFP® professionals, today announced actions taken to uphold its ethical standards, imposing sanctions on 9 individuals.

Banner|Aetna, an Arizona-based health plan offering integrated coverage and care through a partnership between Banner Health and Aetna, a CVS Health company, is participating in the 2026 Phoenix Heart Walk on March 28.

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Ramaco Resources, Inc. (NASDAQ: METC) between July 31, 2025 and October 23, 2025. Ramaco describes itself as a company that “engages in the mining, development, and sale of coal and rare earth minerals.”

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1

Southern California Edison today announced a major milestone in the Wildfire Recovery Compensation Program, with more than 1,000 compensation offers extended to individuals and businesses impacted by the Eaton Fire. The program has offered nearly $380 million in relief to more than 2,800 claimants.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 26, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ:SMCI) securities between April 30, 2024 and March 19, 2026, inclusive (the “Class Period”).

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Plug Power Inc. (NASDAQ: PLUG) between January 17, 2025 and November 13, 2025. Plug Power describes itself as a company that “provides hydrogen fuel cell turnkey solutions for the electric mobility and stationary power markets in North America and Europe.”

AM Best has affirmed the Financial Strength Rating of A+ (Superior), the Long-Term Issuer Credit Rating of “aa” (Superior), and the Mexico National Scale Rating of “aaa.MX” (Exceptional) of Allianz México, S.A., Compañía de Seguros (Allianz Mexico) (Mexico City, Mexico). The outlook of these Credit Ratings (ratings) is stable.

Emera Incorporated (“Emera” or the “Company”) (TSX/NYSE: EMA) announced today that Emera US Finance, LLC (the “Issuer”) has completed the sale of US$750 million aggregate principal amount of United States dollar denominated senior notes, consisting of US$450 million aggregate principal amount of 4.500% senior notes due 2029 (the “2029 Notes”) and US$300 million aggregate principal amount of 5.200% senior notes due 2033 (the “2033 Notes” and, together with the 2029 Notes, the “Notes”). The Notes are fully and unconditionally guaranteed by Emera and Emera US Holdings Inc. (“EUSHI, and together with Emera, the “Guarantors”). EUSHI is an indirect, wholly-owned subsidiary of Emera and the Issuer is an indirect, wholly-owned subsidiary of Emera. Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Scotia Capital (USA) Inc. and Wells Fargo Securities, LLC acted as joint book-running managers in connection with the Notes offering.

(RSAC) Absolute Security, an enterprise cyber resilience leader, today announced the first honorees for the inaugural Resilient CISO Award and winners of the Trailblazer Awards. The Resilient CISO Award was sponsored in partnership with CyberRisk Alliance/SC Media. The Trailblazer Awards are a category created by a special panel of industry security and risk leaders. Honorees, winners, and finalists were announced at special events during RSAC 2026.

The Coca-Cola Company invites fans in Kansas City to see the most coveted Trophy in the world ahead of FIFA World Cup 2026™. The FIFA World Cup 2026™ Trophy Tour by Coca-Cola will be open to the public at the Green Space at Westport Plaza April 17, 2026, for fans to experience fútbol's most desired prize, the FIFA World Cup™ Original Trophy.

Herschend Family Entertainment Corporation (“Herschend”), the world’s largest family-held themed attractions company, has completed its acquisition of Silverwood Theme Park and Boulder Beach Water Park (“Silverwood”) from Silverwood, Inc. This follows the signing of an exclusive terms sheet announced in November 2025.

The Coca-Cola Company invites fans in Kansas City to see the most coveted Trophy in the world ahead of FIFA World Cup 2026™. The FIFA World Cup 2026™ Trophy Tour by Coca-Cola will be open to the public outside of the entrance to Kansas City Live! in the Power & Light District at 14th Street & Grand Boulevard on April 18-19, 2026, for fans to experience fútbol’s most desired prize, the FIFA World Cup™ Original Trophy.